Loxo Oncology
Loxo Oncology, Inc.
281 Tresser Blvd, 9th Floor
Stamford, CT 06901
Phone: (203) 653-3880Website: https://www.loxooncology.com/Careers: www.loxooncology.com/careers
Latest news
- FDA Approves Vitrakvi (larotrectinib) for TRK Fusion Cancers
26 November 2018 - Larotrectinib Delivers 81% Overall Response Rate in an Expanded Dataset of 109 TRK Fusion Cancer Patients Across Ages and Tumor Types
21 October 2018 - FDA Accepts Larotrectinib New Drug Application and Grants Priority Review
29 May 2018 - Loxo Oncology Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancer
26 March 2018 - Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine
21 February 2018 - Loxo Oncology Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancers
20 December 2017 - Loxo Oncology Announces Updated Larotrectinib Pediatric Clinical Trial Data Demonstrating Continued Durability of Response in TRK Fusion Cancers
12 December 2017 - Loxo Oncology Breakthrough Therapy Larotrectinib Demonstrates 76 Percent Confirmed Objective Response Rate in TRK Fusion Adult and Pediatric Cancers as Presented at the American Society of Clinical Oncology
3 June 2017
Drugs Associated with Loxo Oncology, Inc.
Loxo Oncology, Inc. manufactures, markets and/or distributes more than 2 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Brand/Generic Name | Reviews | Rating |
---|---|---|
Retevmo
Generic name: selpercatinib Drug class: multikinase inhibitors |
4 reviews | 10 / 10 |
Vitrakvi
Generic name: larotrectinib Drug class: multikinase inhibitors |
||
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |